Valeant SEC Investigation

Probes Reporter, an independent publisher of investment research that focuses on public company interactions with the SEC, said last week that Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is likely facing a new SEC investigation that hasn't been disclosed to the investment community. Probes...